EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ZVS101e: AAV-mediated gene replacement therapy for Bietti crystalline corneoretinal dystrophy (BCD)

Liping Yang, Wang Li, Jinlu Zhang, Shaohong Chen, Jing Qiao, Baoyuan Qu, Fan Zhang, Xiuping Shen, Hiu Ying Enne Leung, Dennis S C Lam

Asia-Pacific Journal of Ophthalmology · 2026-05 · 15 (3) · 100320

DOI: 10.1016/j.apjo.2026.100320 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2026-05. Verfasst von Liping Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Vision Loss and Restoration, Department of Ophthalmology, Ministry of Education, Peking University Third Hospital, Beijing, China. …. Hauptthemen laut MEDLINE: Corneal Dystrophies, Hereditary, Cytochrome P450 Family 4, Dependovirus, Gene Therapy Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Science and Technology Planning Project, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Corneal Dystrophies, HereditaryCytochrome P450 Family 4DependovirusGene Therapy AgentsGenetic TherapyRetinal DiseasesHumansGenetic Vectors

Stichwörter der Autor:innen

AAVBCDCYP4V2Clinical trialRare diseaseSuprachoroidal space injection

Substanzen

CYP4V2 protein, humanCytochrome P450 Family 4

Autor:innen und Institutionen

  • Key Laboratory of Vision Loss and Restoration, Department of Ophthalmology, Ministry of Education, Peking University Third Hospital, Beijing, China. Electronic address: alexlipingyang@bjmu.edu.cn.
  • CHIGENOVO Co., LTD, Beijing, China.
  • The Primasia International Eye Research Institute (PIERI), School of Medicine, The Chinese University of Hong Kong (Shenzhen), Shenzhen, China; The C-MER Dennis Lam & Partners Eye Center, C-MER International Eye Care Gr…

Förderung

  • National Natural Science Foundation of China
  • Beijing Science and Technology Planning Project
  • National Key Research and Development Program of China

Zitieren

APA

Yang, L., Li, W., Zhang, J., Chen, S., Qiao, J., Qu, B., Zhang, F., Shen, X., Leung, H. Y. E., & Lam, D. S. C. (2026). ZVS101e: AAV-mediated gene replacement therapy for Bietti crystalline corneoretinal dystrophy (BCD). Asia-Pacific Journal of Ophthalmology, 15(3), 100320. https://doi.org/10.1016/j.apjo.2026.100320

Vancouver

Yang L, Li W, Zhang J, Chen S, Qiao J, Qu B, et al. ZVS101e: AAV-mediated gene replacement therapy for Bietti crystalline corneoretinal dystrophy (BCD). Asia-Pacific Journal of Ophthalmology. 2026;15(3):100320. doi:10.1016/j.apjo.2026.100320

BibTeX
@article{Yang2026,
  author = {Yang, Liping and Li, Wang and Zhang, Jinlu and Chen, Shaohong and Qiao, Jing and Qu, Baoyuan and Zhang, Fan and Shen, Xiuping and Leung, Hiu Ying Enne and Lam, Dennis S C},
  title = {ZVS101e: AAV-mediated gene replacement therapy for Bietti crystalline corneoretinal dystrophy (BCD)},
  journal = {Asia-Pacific Journal of Ophthalmology},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {100320},
  doi = {10.1016/j.apjo.2026.100320}
}
Kostenlos starten →